M&A Deal Summary

Unchained Labs Acquires rap.ID Particle Systems

On March 27, 2018, Unchained Labs acquired information technology company rap.ID Particle Systems

Acquisition Highlights
  • This is Unchained Labs’ 2nd transaction in the Information Technology sector.
  • This is Unchained Labs’ 1st transaction in Germany.

M&A Deal Summary

Date 2018-03-27
Target rap.ID Particle Systems
Sector Information Technology
Buyer(s) Unchained Labs
Deal Type Add-on Acquisition

Target

rap.ID Particle Systems

Berlin, Germany
rap.ID Particle Systems GmbH is a provider of systems used for particle identification in biopharmaceutical development and quality control.

Search 214,877 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Unchained Labs

Pleasanton, California, United States

Category Company
Founded 2015
Sector Test/Measurement Equipment
DESCRIPTION

Unchained Labs is a life science tools company focused on solving problems for biologics and gene therapy researchers. Unchained systems are used by biopharma researchers around the world to analyze and characterize large, complex molecules and to make their research jobs easier. Unchained Labs was founded in 2015 and is based in Pleasanton, California.


DEAL STATS #
Overall 5 of 7
Sector: Information Technology M&A 2 of 2
Type: Add-on Acquisition M&A Deals 5 of 7
Country: Germany M&A 1 of 1
Year: 2018 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-29 Trinean NV

Gentbrugge, Belgium

Trinean NV is an instrumentation company, bringing micro-volume molecular spectroscopy to the next level by combining best in class analytical software with a highly standardized read-out platform. Trinean NV was founded in 2006 and is based in Gentbrugge, Belgium.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-04 NanoView Biosciences

Brighton, Massachusetts, United States

NanoView Biosciences is developing proprietary products that support research, translation, and delivery of precision medicine. The Company was founded on a novel technology platform that uniquely identifies and characterizes exosomes. Its high-throughput, cost-effective analysis solutions enable life science, researchers, to better understand the biology of cellular communication and provide improved insight into how diseases are diagnosed, treated, and monitored. NanoView Biosciences was formed in 2015 and is based in Brighton, Massachusetts.

Buy -